James Chung, M.D., PhD.Chief Medical Officer at Kyverna Therapeutics
James Chung, MD, PhD is the Chief Medical Officer of Kyverna Therapeutics. Prior to Kyverna Dr. Chung was at Amgen where he began in Early Development and served as the Inflammation Therapeutic Area Head. He also worked in late-stage development as the Global Development Leader for Enbrel and as the Inflammation head for the US and Global Medical Organizations. Prior to Amgen he worked in early development, Inflammation, at Pfizer. Dr. Chung obtained his MD and PhD in immunology at the University of Pennsylvania where he also completed his residency in Internal Medicine and fellowship in Rheumatology.
Development of Anti-CD19 CAR T-Cell Therapy for Autoimmune Diseases, 4:00pmView Session